Weekly nab-paclitaxel for progressive or symptomatic desmoid tumors: A multicenter single arm phase II trial from the Spanish Group for Research on Sarcoma (GEIS)

Simple item page
dc.conference.dateSEP 19-OCT 18, 2020
dc.conference.titleESMO Virtual Congress
dc.contributor.authorMartin Broto, J.
dc.contributor.authorHindi, N.
dc.contributor.authorRedondo, A.
dc.contributor.authorMorales, J. M.
dc.contributor.authorMarcilla, D.
dc.contributor.authorValverde, C.
dc.contributor.authorLuna, P.
dc.contributor.authorDiaz-Beveritge, R.
dc.contributor.authorMartinez-Trufero, J.
dc.contributor.authorLopez-Martin, J. A.
dc.contributor.authorMartinez, V.
dc.contributor.authorGutierrez, A.
dc.contributor.authorLopez-Pousa, A.
dc.contributor.authoraffiliation[Martin Broto, J.] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Dept Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Hindi, N.] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Dept Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Redondo, A.] Hosp Univ La Paz, Dept Oncol Med, Madrid, Spain
dc.contributor.authoraffiliation[Martinez, V.] Hosp Univ La Paz, Dept Oncol Med, Madrid, Spain
dc.contributor.authoraffiliation[Morales, J. M.] Hosp Univ Virgen del Rocio, Dept Radiol, Seville, Spain
dc.contributor.authoraffiliation[Marcilla, D.] Hosp Univ Virgen del Rocio, Dept Pathol, Seville, Spain
dc.contributor.authoraffiliation[Valverde, C.] Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Luna, P.] Hosp Univ Son Espases, Med Oncol, Palma De Mallorca, Spain
dc.contributor.authoraffiliation[Diaz-Beveritge, R.] Hosp Univ La Fe, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Martinez-Trufero, J.] Hosp Univ Miguel Servet, Med Oncol, Zaragoza, Spain
dc.contributor.authoraffiliation[Lopez-Martin, J. A.] Hosp Univ Doce Octubre, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Gutierrez, A.] Hosp Univ Son Espases, Hematol, Palma De Mallorca, Spain
dc.contributor.authoraffiliation[Lopez-Pousa, A.] Hosp Santa Creu & Sant Pau, Med Oncol, Barcelona, Spain
dc.contributor.funderSpanish Group for Research on Sarcoma (GEIS)
dc.contributor.funderCelgene
dc.date.accessioned2025-01-07T16:40:54Z
dc.date.available2025-01-07T16:40:54Z
dc.date.issued2020-09-01
dc.identifier.doi10.1016/j.annonc.2020.08.1850
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420418460/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27939
dc.identifier.wosID573469102211
dc.issue.number4
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Sevilla (IBIS)
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS975-S975
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleWeekly nab-paclitaxel for progressive or symptomatic desmoid tumors: A multicenter single arm phase II trial from the Spanish Group for Research on Sarcoma (GEIS)
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files

Collections

Instituto de Investigación Biomédica de Sevilla (IBIS)
SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía